Results
1 -
10 of
39O'Connor Liam J, Cazares-Körner Cindy, Saha Jaideep, Evans Charles NG, Stratford Michael R, Hammond Ester M, Conway Stuart.
Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302)., Org. Chem. Front., 2015 Hypoxia-Directed Drug Strategies to Target the Tumor Microenvironment, Tumor Microenvironment and Cellular Stress Prodrug Strategies for Targeting Tumour Hypoxia, Hypoxia and Cancer The Leukemic Bone Marrow Microenvironment: Targeting Hypoxia with Hypoxia-Activated Prodrugs, Targeted Therapy of Acute Myeloid Leukemia Emerging Systemic and Targeted Therapies, Multimodality Management of Borderline Resectable Pancreatic Cancer Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed, Current and Emerging Therapies in Pancreatic Cancer Atomic Mass and Nuclear Binding Energy for Th-302 (Thorium), Nuclei with Z = 55 - 100 The Biology of Melanoma, Genetics of Melanoma Development of Hypoxia: Activated Cytotoxic Prodrug, Innovation of Diagnosis and Treatment for Pancreatic Cancer